|
US6538037B2
(en)
|
1991-01-08 |
2003-03-25 |
Bone Care International, Inc. |
Methods for preparation and use of 1α,24(S)-dihydroxyvitamin D2
|
|
US6573256B2
(en)
|
1996-12-30 |
2003-06-03 |
Bone Care International, Inc. |
Method of inhibiting angiogenesis using active vitamin D analogues
|
|
US6566353B2
(en)
|
1996-12-30 |
2003-05-20 |
Bone Care International, Inc. |
Method of treating malignancy associated hypercalcemia using active vitamin D analogues
|
|
US6503893B2
(en)
|
1996-12-30 |
2003-01-07 |
Bone Care International, Inc. |
Method of treating hyperproliferative diseases using active vitamin D analogues
|
|
US6087350A
(en)
|
1997-08-29 |
2000-07-11 |
University Of Pittsburgh Of The Commonwealth System Of Higher Education |
Use of pretreatment chemicals to enhance efficacy of cytotoxic agents
|
|
AUPP332898A0
(en)
*
|
1998-05-04 |
1998-05-28 |
Unisearch Limited |
Pharmaceutical composition
|
|
AU765846B2
(en)
*
|
1998-05-04 |
2003-10-02 |
Mrc Holdings Pty Limited |
Pharmaceutical composition
|
|
US20030031670A1
(en)
*
|
1999-11-08 |
2003-02-13 |
Jack R. Wands |
Diagnosis and treatment of malignant neoplasms
|
|
AU1917101A
(en)
*
|
1999-11-11 |
2001-06-06 |
Eli Lilly And Company |
Oncolytic combinations for the treatment of cancer
|
|
DE10032587A1
(de)
*
|
2000-07-05 |
2002-01-17 |
Bayer Ag |
4-Alkoxy-cyclohexan-1-amino-carbonsäureester und Verfahren zu ihrer Herstellung
|
|
AU781168B2
(en)
*
|
2001-01-26 |
2005-05-12 |
Pfizer Products Inc. |
Method of treating certain cancers using an estrogen agonist/antagonist
|
|
WO2002076454A1
(en)
*
|
2001-03-26 |
2002-10-03 |
Unisearch Limited |
Method for treatment of cancer and compositions for use therein
|
|
JP2004026811A
(ja)
*
|
2002-04-30 |
2004-01-29 |
Kiyoshi Hashizume |
ビタミンｄ３誘導体を含有する抗癌作用を増強させるための薬剤
|
|
AU2002330482A1
(en)
|
2002-09-04 |
2004-03-29 |
Perseus Proteomics Inc. |
Method of diagnosing cancer by detecting gpc3
|
|
WO2004047673A2
(en)
*
|
2002-11-21 |
2004-06-10 |
Novacea, Inc. |
Treatment of liver disease with active vitamin d compounds
|
|
WO2005027918A1
(en)
*
|
2003-09-19 |
2005-03-31 |
Pfizer Products Inc. |
Pharmaceutical compositions and methods comprising combinations of 2-alkylidene-19-nor-vitamin d derivatives and a cyclooxgenase-2 inhibitor
|
|
WO2005027928A1
(en)
*
|
2003-09-19 |
2005-03-31 |
Pfizer Products Inc. |
2-alkylidene-19-nor-vit amin d derivatives for the treatment of hypocalcemic tetany or hyproparathyroidism
|
|
WO2005027922A1
(en)
*
|
2003-09-19 |
2005-03-31 |
Pfizer Products Inc. |
2-alkylidene-19-nor-vitamin d derivatives for the treatment of hypogonadism or andropause
|
|
WO2005027916A1
(en)
*
|
2003-09-19 |
2005-03-31 |
Pfizer Products Inc. |
Pharmaceutical compositions and methods comprising combinations of 2-alkylidene-19-nor-vitamin d derivatives and aromatase inhibitors
|
|
BRPI0414448A
(pt)
*
|
2003-09-19 |
2006-11-14 |
Pfizer Prod Inc |
composições farmacêuticas e métodos compreendendo combinações de derivados de 2-alquilideno-19-nor-vitamina d e um agonista/antagonista de estrogênio
|
|
US7094775B2
(en)
|
2004-06-30 |
2006-08-22 |
Bone Care International, Llc |
Method of treating breast cancer using a combination of vitamin D analogues and other agents
|
|
JP4248544B2
(ja)
*
|
2005-12-19 |
2009-04-02 |
株式会社椿本チエイン |
伝動装置用可動ガイド
|
|
CN102655869B
(zh)
*
|
2009-08-14 |
2016-08-10 |
博格有限责任公司 |
用于治疗脱发的维生素d3及其类似物
|
|
CN105473147A
(zh)
|
2013-04-24 |
2016-04-06 |
萨克生物研究学院 |
维生素d受体/smad基因组回路门纤维化反应
|
|
WO2014197680A1
(en)
*
|
2013-06-05 |
2014-12-11 |
Salk Institute For Biological Studies |
Vitamin d receptor agonists to treat diseases involving cxcl12 activity
|
|
JP2016124818A
(ja)
*
|
2014-12-26 |
2016-07-11 |
日本化薬株式会社 |
転移性肝癌治療薬及び転移性肝癌の治療方法
|
|
WO2016167977A1
(en)
|
2015-04-14 |
2016-10-20 |
Mayo Foundation For Medical Education And Research |
Methods and materials for delivering agents to liver tissue
|
|
WO2019023149A1
(en)
|
2017-07-24 |
2019-01-31 |
Salk Institute For Biological Studies |
USE OF BROMODOMAIN-CONTAINING PROTEIN-9 ANTAGONISTS IN ASSOCIATION WITH VITAMIN D RECEPTOR AGONISTS IN THE TREATMENT OF DIABETES
|
|
CN116059364B
(zh)
*
|
2021-11-04 |
2025-07-11 |
上海健康医学院 |
Dhcr7下调剂在减弱酒精诱导的肝脏肿瘤中的应用
|